Moreover, SARS-CoV-2 itself causes endothelial dysfunction, which may potentially result in accelerated development of atherosclerosis in COVID-19 survivors; in such cases, patients with additionally elevated Lp(a) might be particularly vulnerable to this effect [24]. This evidence concerns the gene LPA and endothelial dysfunction.